VITA LIFE SCIENCES LIMITED (2) (ASX.VLS)

company's shares are re-quoted today on ASX under Code VSC - see separate record under that Code

the company has issued a prospectus offering 34m shares at 20 cents a share to raise $6.8m - if successful this will facilitate the re-quotation of the company's shares

all 8 resolutions considered at the company's AGM today were approved - one of the resolutions dealt with the consolidation of shares on a one for four basis

an AGM is to be held at Level 1, St Kilda Road Towers, 1 Queens Road, Melbourne Victoria, 3004, Australia at 11.00am Melbourne time on Thursday, 31 May 2007 - among other resolutions to be considered is a proposal for the consolidation of capital on a one for four basis and a proposal to issue 34,000,000 fully paid ordinary shares in the capital of the Company at an issue price of not less than $0.20 per share, including up to 6,000,000 rights to those shares to existing option holders at the Record Date, and otherwise on the terms set out in the prospectus to be issued by the Company

company provides notice of a general meeting to be held at Boardroom 1, Level 1, St Kilda Road Towers, 1 Queens Road, Melbourne on 12 April 2006 at 11:30am - the main purpose of the meeting is to consider proposals to discharge the company's obligations to noteholders which amounts to $19.2m - the notes are due for repayment on 14 April 2006

the annual accounts to Dec 04 will reveal a loss of $2m and results should be available by mid April with an AGM to be held mid May - management still believe the company will survive - if all goes according to plan the company intends to begin the process of seeking a relisting at some time over the next 12 months

ASIC refuses to get involved in facilitating remedies against Seng Meng Pang

company advises that the High Court of Singapore has found in its favour over the action against former MD Mr Seng Meng Pang - it has called on ASIC to prosecute and ASX to fast-track its relisting

litigation is underway in Singapore - this is likely to be a drawn out process

seeking update since 10 mar 04

company advises that the recall of Pan-manufactured products has cost shareholders in excess of $10 million - the future of VLS remains troubled and challenging

advises that the company's case against former MD Pang Seng Meng is set down to commence on 1 March 2004

directors and management advise that a total of $12.86 million of notes were issued - of this amount $6.65 million represented conversions of existing shareholder and third party loans - a further $2.64 million was used to retire existing shareholder and third party debt with a net amount of $3.57 million available for the company's use

company advises it is important the holding locks remain on Mr Pang's shares and that while it will seek a relisting on ASX it may be a year or so before that can be achieved

the company failed to lodge its half yearly financial statements on time and ASIC has taken action to prevent the company from using the limited disclosure regime when raising money

delisted following failure by the company to rectify a breach of Listing Rule 8.10

the company says that to comply with Listing Rule 8.10, it would need to "obtain a court order which provides legal justification for retaining the holding locks on the shares of the former managing director of Vita Life" - on 14 May 2003 it said it was considering the options, seeking further legal advice and would announce its future course of action with regards to this matter in due course

name changed from Macarthur National Limited